IDXX
IDEXX Laboratories, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-20
Figures on this page computed 2026-11-08 13:42 UTC
Last close
698.55USD
Market data, 2026-11-04
Weekly closes, 2026-05-15 to 2026-11-04
Over that span: +32.1%
Except where said otherwise: 10-K for 2025, filed 2026-02-20
51.3xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-20
54.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
24.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
24.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
0.36Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Price is the furthest below its sector's middle: 0.09 against 0.36 on the market's range.
- Growth9.7%59 of 100, above its sector
- Returns on capital54.3%98 of 100, above its sector
- Margins61.8%88 of 100, above its sector
- Price51.3x9 of 100, below its sector
- Safety0.3669 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
5 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-02-20
- Sales1.46x
Its own average over 10 years, 2.95B.
- Profit1.74x
Its own average over 10 years, 608.8M.
- Free cash flow1.97x
Its own average over 10 years, 537.1M.
- Debt0.76x
Its own average over 10 years, 756.8M.
- Price1.76x
Its own average over 11 years, 397. Market data, 2026-11-04
Free cash flow is furthest from its own average, at 1.97 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 110.9 | 118.5 | 98.6 |
| 2018-12-31 | 124.7 | 169.8 | 97.3 |
| 2019-12-31 | 135.6 | 192.6 | 96.3 |
| 2020-12-31 | 152.5 | 262.0 | 95.4 |
| 2021-12-31 | 181.1 | 335.4 | 95.3 |
| 2022-12-31 | 189.7 | 305.8 | 93.1 |
| 2023-12-31 | 206.2 | 380.6 | 92.4 |
| 2024-12-31 | 219.5 | 399.9 | 91.6 |
| 2025-12-31 | 242.4 | 477.1 | 89.2 |
How sales was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
How profit was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
How shares in issue was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Figures behind the shape
Growth
9.7%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate9.7%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Five-year EPS growth rate14.1%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
One-year change in net income19.3%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Returns on capital
54.3%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital54.3%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
Return on equity66.0%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
Return on assets31.6%
Net Income / Total Assets x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
Margins
61.8%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin61.8%
Gross Profit / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Operating margin31.6%
Operating Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Net margin24.6%
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Free cash flow margin24.6%
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Price
51.3xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings51.3x
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-20
Price to book34.1x10-Q for 2025, filed 2026-11-02
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000135
- Reported in
- USD
- computed
- 10-Q for 2025, filed 2026-11-02
- computed
- 10-K for 2025, filed 2026-02-20
EV to EBITDA36.7x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-02-20
Price to sales ratio12.7x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Safety
0.36safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity0.36
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
Current ratio1.2310-Q for 2025, filed 2026-11-02
Current Assets / Current Liabilities
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000135
- Reported in
- USD
- 10-Q for 2025, filed 2026-11-02
- 10-Q for 2025, filed 2026-11-02
Interest coverage35.0x
Operating Income / Interest Expense
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Altman Z-Score24.22
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- Computed from the 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
What it pays out
n/aWe do not hold this figure for this company, so there is nothing to place.
more, and better covered, is higher, with no cohort held
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.